je.st
news
China Rejects Gilead's Sovaldi Patent Application
2015-06-21 11:47:21| Biotech - Topix.net
China's State Intellectual Property Office has decided to reject a Gilead Sciences, Inc. 's patent application relating to its hepatitis C drug sofosbuvir, marketed as Sovaldi. The rejection could have important implications for Gilead, its generic drug competitors and HCV patients worldwide.
Tags: china
application
patent
rejects
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||